Sintx Technologies (SINT) Profit After Tax Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -112.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.74% |
| Dec 31, 2025 | 17.19% |
| Sep 30, 2025 | -9.12% |
| Jun 30, 2025 | 2.64% |
| Mar 31, 2025 | 6.95% |
| Dec 31, 2024 | 7.26% |
| Sep 30, 2024 | -38.61% |
| Jun 30, 2024 | -0.08% |
| Mar 31, 2024 | 30.45% |
| Dec 31, 2023 | -10.91% |
| Sep 30, 2023 | -9.38% |
| Jun 30, 2023 | 15.21% |
| Mar 31, 2023 | -31.05% |
| Dec 31, 2022 | -57.83% |
| Sep 30, 2022 | -23.50% |
| Jun 30, 2022 | -50.97% |
| Mar 31, 2022 | -20.43% |
| Dec 31, 2021 | -26.29% |
| Sep 30, 2021 | 7.57% |
| Jun 30, 2021 | -0.27% |
| Mar 31, 2021 | 8.93% |
| Dec 31, 2020 | 30.02% |
| Sep 30, 2020 | -17.92% |
| Jun 30, 2020 | -33.24% |
| Mar 31, 2020 | 62.40% |
| Dec 31, 2019 | 4.08% |
| Sep 30, 2019 | 34.67% |
| Jun 30, 2019 | 47.57% |
| Mar 31, 2019 | 21.66% |
| Dec 31, 2018 | 24.64% |
| Sep 30, 2018 | 33.60% |
| Jun 30, 2018 | 28.36% |
| Mar 31, 2018 | 13.47% |
| Dec 31, 2017 | 19.57% |
| Sep 30, 2017 | 32.95% |
| Jun 30, 2017 | 49.52% |
| Mar 31, 2017 | 52.28% |
| Dec 31, 2016 | -54.64% |
| Sep 30, 2016 | -30.24% |
| Jun 30, 2016 | -18.21% |
| Mar 31, 2016 | 1.40% |